nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2B6—Thiotepa—sarcoma	0.276	0.844	CbGbCtD
Memantine—CYP2B6—Doxorubicin—sarcoma	0.0511	0.156	CbGbCtD
Memantine—GRIN2A—CREB phosphorylation through the activation of CaMKII—CREB1—sarcoma	0.00172	0.0327	CbGpPWpGaD
Memantine—GRIN1—CREB phosphorylation through the activation of CaMKII—CREB1—sarcoma	0.0015	0.0285	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of CaMKII—CREB1—sarcoma	0.00146	0.0278	CbGpPWpGaD
Memantine—GRIN2A—CREB phosphorylation through the activation of Ras—CREB1—sarcoma	0.00112	0.0213	CbGpPWpGaD
Memantine—GRIN2A—Hypothetical Network for Drug Addiction—CREB1—sarcoma	0.00104	0.0197	CbGpPWpGaD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—CREB1—sarcoma	0.00098	0.0186	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—CREB1—sarcoma	0.000955	0.0181	CbGpPWpGaD
Memantine—GRIN2A—Post NMDA receptor activation events—CREB1—sarcoma	0.000924	0.0175	CbGpPWpGaD
Memantine—GRIN1—Hypothetical Network for Drug Addiction—CREB1—sarcoma	0.000905	0.0172	CbGpPWpGaD
Memantine—GRIN2B—Hypothetical Network for Drug Addiction—CREB1—sarcoma	0.000883	0.0168	CbGpPWpGaD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CREB1—sarcoma	0.000851	0.0162	CbGpPWpGaD
Memantine—GRIN1—Post NMDA receptor activation events—CREB1—sarcoma	0.000806	0.0153	CbGpPWpGaD
Memantine—GRIN2B—Post NMDA receptor activation events—CREB1—sarcoma	0.000786	0.0149	CbGpPWpGaD
Memantine—CYP2A6—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000754	0.0143	CbGpPWpGaD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CREB1—sarcoma	0.000743	0.0141	CbGpPWpGaD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CREB1—sarcoma	0.000724	0.0137	CbGpPWpGaD
Memantine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—sarcoma	0.000715	0.0136	CbGpPWpGaD
Memantine—GRIN2B—ErbB4 signaling events—MDM2—sarcoma	0.00068	0.0129	CbGpPWpGaD
Memantine—GRIN1—Mecp2 and Associated Rett Syndrome—CREB1—sarcoma	0.000655	0.0124	CbGpPWpGaD
Memantine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—sarcoma	0.000624	0.0118	CbGpPWpGaD
Memantine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—sarcoma	0.000608	0.0115	CbGpPWpGaD
Memantine—CYP2A6—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000596	0.0113	CbGpPWpGaD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—sarcoma	0.000541	0.0103	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—PLCG1—sarcoma	0.000528	0.01	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—PLCG1—sarcoma	0.000515	0.00978	CbGpPWpGaD
Memantine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—sarcoma	0.00051	0.00968	CbGpPWpGaD
Memantine—CYP2B6—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000481	0.00913	CbGpPWpGaD
Memantine—GRIN1—EPHB-mediated forward signaling—SRC—sarcoma	0.000479	0.00909	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—EZR—sarcoma	0.000479	0.00909	CbGpPWpGaD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—sarcoma	0.000473	0.00897	CbGpPWpGaD
Memantine—GRIN2B—EPHB-mediated forward signaling—SRC—sarcoma	0.000467	0.00887	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—EZR—sarcoma	0.000467	0.00886	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MYOG—sarcoma	0.000451	0.00856	CbGpPWpGaD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—sarcoma	0.000445	0.00844	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MYOG—sarcoma	0.000439	0.00834	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—KDR—sarcoma	0.000436	0.00828	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—sarcoma	0.000434	0.00823	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—KDR—sarcoma	0.000425	0.00807	CbGpPWpGaD
Memantine—GRIN2A—Post NMDA receptor activation events—HRAS—sarcoma	0.00042	0.00797	CbGpPWpGaD
Memantine—DRD2—Hypothetical Network for Drug Addiction—CREB1—sarcoma	0.000415	0.00789	CbGpPWpGaD
Memantine—CYP2C19—Melatonin metabolism and effects—FOXO1—sarcoma	0.000393	0.00746	CbGpPWpGaD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—sarcoma	0.000387	0.00734	CbGpPWpGaD
Memantine—GRIN1—Post NMDA receptor activation events—HRAS—sarcoma	0.000366	0.00695	CbGpPWpGaD
Memantine—Asthenia—Vincristine—sarcoma	0.000365	0.000589	CcSEcCtD
Memantine—Vomiting—Thiotepa—sarcoma	0.000365	0.000589	CcSEcCtD
Memantine—Pneumonia—Epirubicin—sarcoma	0.000365	0.000588	CcSEcCtD
Memantine—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000363	0.0069	CbGpPWpGaD
Memantine—Infestation NOS—Epirubicin—sarcoma	0.000362	0.000584	CcSEcCtD
Memantine—Infestation—Epirubicin—sarcoma	0.000362	0.000584	CcSEcCtD
Memantine—Vomiting—Dactinomycin—sarcoma	0.000362	0.000584	CcSEcCtD
Memantine—Rash—Thiotepa—sarcoma	0.000362	0.000584	CcSEcCtD
Memantine—Bronchitis—Doxorubicin—sarcoma	0.000362	0.000583	CcSEcCtD
Memantine—Dermatitis—Thiotepa—sarcoma	0.000362	0.000583	CcSEcCtD
Memantine—Headache—Thiotepa—sarcoma	0.00036	0.00058	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000359	0.000579	CcSEcCtD
Memantine—Rash—Dactinomycin—sarcoma	0.000359	0.000579	CcSEcCtD
Memantine—Decreased appetite—Etoposide—sarcoma	0.000358	0.000578	CcSEcCtD
Memantine—Pancytopenia—Doxorubicin—sarcoma	0.000357	0.000576	CcSEcCtD
Memantine—GRIN2B—Post NMDA receptor activation events—HRAS—sarcoma	0.000357	0.00677	CbGpPWpGaD
Memantine—Renal failure—Epirubicin—sarcoma	0.000356	0.000575	CcSEcCtD
Memantine—Gastrointestinal disorder—Etoposide—sarcoma	0.000356	0.000574	CcSEcCtD
Memantine—GRIN1—EPH-Ephrin signaling—MMP2—sarcoma	0.000356	0.00676	CbGpPWpGaD
Memantine—Asthenia—Mitoxantrone—sarcoma	0.000356	0.000574	CcSEcCtD
Memantine—Fatigue—Etoposide—sarcoma	0.000355	0.000573	CcSEcCtD
Memantine—Neuropathy peripheral—Epirubicin—sarcoma	0.000355	0.000573	CcSEcCtD
Memantine—Pain—Etoposide—sarcoma	0.000353	0.000569	CcSEcCtD
Memantine—Constipation—Etoposide—sarcoma	0.000353	0.000569	CcSEcCtD
Memantine—Conjunctivitis—Epirubicin—sarcoma	0.000352	0.000568	CcSEcCtD
Memantine—Urinary tract infection—Epirubicin—sarcoma	0.000352	0.000568	CcSEcCtD
Memantine—Dysuria—Doxorubicin—sarcoma	0.000352	0.000567	CcSEcCtD
Memantine—Neutropenia—Doxorubicin—sarcoma	0.000352	0.000567	CcSEcCtD
Memantine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00035	0.000564	CcSEcCtD
Memantine—Diarrhoea—Vincristine—sarcoma	0.000348	0.000562	CcSEcCtD
Memantine—Pollakiuria—Doxorubicin—sarcoma	0.000347	0.00056	CcSEcCtD
Memantine—GRIN2B—EPH-Ephrin signaling—MMP2—sarcoma	0.000347	0.00659	CbGpPWpGaD
Memantine—Haematuria—Epirubicin—sarcoma	0.000346	0.000557	CcSEcCtD
Memantine—Hepatobiliary disease—Epirubicin—sarcoma	0.000343	0.000553	CcSEcCtD
Memantine—Weight increased—Doxorubicin—sarcoma	0.000342	0.000552	CcSEcCtD
Memantine—Epistaxis—Epirubicin—sarcoma	0.000342	0.000551	CcSEcCtD
Memantine—GRIN1—Developmental Biology—EZR—sarcoma	0.000342	0.00648	CbGpPWpGaD
Memantine—Nausea—Thiotepa—sarcoma	0.000341	0.00055	CcSEcCtD
Memantine—Weight decreased—Doxorubicin—sarcoma	0.00034	0.000549	CcSEcCtD
Memantine—Sinusitis—Epirubicin—sarcoma	0.00034	0.000548	CcSEcCtD
Memantine—Feeling abnormal—Etoposide—sarcoma	0.00034	0.000548	CcSEcCtD
Memantine—Hyperglycaemia—Doxorubicin—sarcoma	0.000339	0.000547	CcSEcCtD
Memantine—Diarrhoea—Mitoxantrone—sarcoma	0.000339	0.000547	CcSEcCtD
Memantine—Nausea—Dactinomycin—sarcoma	0.000338	0.000546	CcSEcCtD
Memantine—Agranulocytosis—Epirubicin—sarcoma	0.000338	0.000545	CcSEcCtD
Memantine—Pneumonia—Doxorubicin—sarcoma	0.000337	0.000544	CcSEcCtD
Memantine—Gastrointestinal pain—Etoposide—sarcoma	0.000337	0.000544	CcSEcCtD
Memantine—GRIN1—EPHB-mediated forward signaling—HRAS—sarcoma	0.000337	0.0064	CbGpPWpGaD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—sarcoma	0.000337	0.0064	CbGpPWpGaD
Memantine—Dizziness—Vincristine—sarcoma	0.000337	0.000543	CcSEcCtD
Memantine—Infestation NOS—Doxorubicin—sarcoma	0.000335	0.000541	CcSEcCtD
Memantine—Infestation—Doxorubicin—sarcoma	0.000335	0.000541	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—EZR—sarcoma	0.000333	0.00632	CbGpPWpGaD
Memantine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000332	0.000536	CcSEcCtD
Memantine—Bradycardia—Epirubicin—sarcoma	0.000331	0.000534	CcSEcCtD
Memantine—Renal failure—Doxorubicin—sarcoma	0.00033	0.000532	CcSEcCtD
Memantine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000329	0.00053	CcSEcCtD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—sarcoma	0.000329	0.00624	CbGpPWpGaD
Memantine—GRIN2B—EPHB-mediated forward signaling—HRAS—sarcoma	0.000329	0.00624	CbGpPWpGaD
Memantine—Urticaria—Etoposide—sarcoma	0.000328	0.000528	CcSEcCtD
Memantine—Haemoglobin—Epirubicin—sarcoma	0.000327	0.000527	CcSEcCtD
Memantine—Rhinitis—Epirubicin—sarcoma	0.000326	0.000526	CcSEcCtD
Memantine—Abdominal pain—Etoposide—sarcoma	0.000326	0.000526	CcSEcCtD
Memantine—Body temperature increased—Etoposide—sarcoma	0.000326	0.000526	CcSEcCtD
Memantine—Urinary tract infection—Doxorubicin—sarcoma	0.000326	0.000526	CcSEcCtD
Memantine—Conjunctivitis—Doxorubicin—sarcoma	0.000326	0.000526	CcSEcCtD
Memantine—Hepatitis—Epirubicin—sarcoma	0.000325	0.000525	CcSEcCtD
Memantine—Haemorrhage—Epirubicin—sarcoma	0.000325	0.000525	CcSEcCtD
Memantine—Hypoaesthesia—Epirubicin—sarcoma	0.000324	0.000522	CcSEcCtD
Memantine—Vomiting—Vincristine—sarcoma	0.000324	0.000522	CcSEcCtD
Memantine—Pharyngitis—Epirubicin—sarcoma	0.000323	0.000521	CcSEcCtD
Memantine—Urinary tract disorder—Epirubicin—sarcoma	0.000321	0.000518	CcSEcCtD
Memantine—Rash—Vincristine—sarcoma	0.000321	0.000518	CcSEcCtD
Memantine—Dermatitis—Vincristine—sarcoma	0.000321	0.000517	CcSEcCtD
Memantine—Oedema peripheral—Epirubicin—sarcoma	0.00032	0.000517	CcSEcCtD
Memantine—Haematuria—Doxorubicin—sarcoma	0.00032	0.000516	CcSEcCtD
Memantine—Connective tissue disorder—Epirubicin—sarcoma	0.00032	0.000516	CcSEcCtD
Memantine—Urethral disorder—Epirubicin—sarcoma	0.000319	0.000514	CcSEcCtD
Memantine—Headache—Vincristine—sarcoma	0.000319	0.000514	CcSEcCtD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000319	0.00605	CbGpPWpGaD
Memantine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000317	0.000511	CcSEcCtD
Memantine—Epistaxis—Doxorubicin—sarcoma	0.000316	0.00051	CcSEcCtD
Memantine—Vomiting—Mitoxantrone—sarcoma	0.000315	0.000508	CcSEcCtD
Memantine—Sinusitis—Doxorubicin—sarcoma	0.000315	0.000507	CcSEcCtD
Memantine—Visual impairment—Epirubicin—sarcoma	0.000314	0.000506	CcSEcCtD
Memantine—Agranulocytosis—Doxorubicin—sarcoma	0.000313	0.000505	CcSEcCtD
Memantine—Rash—Mitoxantrone—sarcoma	0.000313	0.000504	CcSEcCtD
Memantine—Dermatitis—Mitoxantrone—sarcoma	0.000312	0.000504	CcSEcCtD
Memantine—Headache—Mitoxantrone—sarcoma	0.000311	0.000501	CcSEcCtD
Memantine—Erythema multiforme—Epirubicin—sarcoma	0.000308	0.000496	CcSEcCtD
Memantine—Bradycardia—Doxorubicin—sarcoma	0.000306	0.000494	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000306	0.00582	CbGpPWpGaD
Memantine—Eye disorder—Epirubicin—sarcoma	0.000304	0.00049	CcSEcCtD
Memantine—Hypersensitivity—Etoposide—sarcoma	0.000304	0.00049	CcSEcCtD
Memantine—Tinnitus—Epirubicin—sarcoma	0.000303	0.000489	CcSEcCtD
Memantine—Haemoglobin—Doxorubicin—sarcoma	0.000303	0.000488	CcSEcCtD
Memantine—Nausea—Vincristine—sarcoma	0.000302	0.000488	CcSEcCtD
Memantine—Flushing—Epirubicin—sarcoma	0.000302	0.000487	CcSEcCtD
Memantine—Cardiac disorder—Epirubicin—sarcoma	0.000302	0.000487	CcSEcCtD
Memantine—Rhinitis—Doxorubicin—sarcoma	0.000302	0.000487	CcSEcCtD
Memantine—Haemorrhage—Doxorubicin—sarcoma	0.000301	0.000485	CcSEcCtD
Memantine—Hepatitis—Doxorubicin—sarcoma	0.000301	0.000485	CcSEcCtD
Memantine—Hypoaesthesia—Doxorubicin—sarcoma	0.0003	0.000483	CcSEcCtD
Memantine—Pharyngitis—Doxorubicin—sarcoma	0.000299	0.000482	CcSEcCtD
Memantine—Urinary tract disorder—Doxorubicin—sarcoma	0.000297	0.000479	CcSEcCtD
Memantine—Oedema peripheral—Doxorubicin—sarcoma	0.000297	0.000478	CcSEcCtD
Memantine—Asthenia—Etoposide—sarcoma	0.000296	0.000477	CcSEcCtD
Memantine—Connective tissue disorder—Doxorubicin—sarcoma	0.000296	0.000477	CcSEcCtD
Memantine—Angiopathy—Epirubicin—sarcoma	0.000295	0.000476	CcSEcCtD
Memantine—Urethral disorder—Doxorubicin—sarcoma	0.000295	0.000476	CcSEcCtD
Memantine—Nausea—Mitoxantrone—sarcoma	0.000294	0.000475	CcSEcCtD
Memantine—Immune system disorder—Epirubicin—sarcoma	0.000294	0.000474	CcSEcCtD
Memantine—Mediastinal disorder—Epirubicin—sarcoma	0.000293	0.000473	CcSEcCtD
Memantine—Chills—Epirubicin—sarcoma	0.000292	0.000471	CcSEcCtD
Memantine—Pruritus—Etoposide—sarcoma	0.000292	0.00047	CcSEcCtD
Memantine—Arrhythmia—Epirubicin—sarcoma	0.000291	0.000469	CcSEcCtD
Memantine—Visual impairment—Doxorubicin—sarcoma	0.00029	0.000468	CcSEcCtD
Memantine—Alopecia—Epirubicin—sarcoma	0.000287	0.000464	CcSEcCtD
Memantine—Mental disorder—Epirubicin—sarcoma	0.000285	0.00046	CcSEcCtD
Memantine—Erythema multiforme—Doxorubicin—sarcoma	0.000285	0.000459	CcSEcCtD
Memantine—Malnutrition—Epirubicin—sarcoma	0.000283	0.000457	CcSEcCtD
Memantine—Diarrhoea—Etoposide—sarcoma	0.000282	0.000455	CcSEcCtD
Memantine—GRIN1—Axon guidance—PTPRC—sarcoma	0.000282	0.00536	CbGpPWpGaD
Memantine—Eye disorder—Doxorubicin—sarcoma	0.000281	0.000454	CcSEcCtD
Memantine—Tinnitus—Doxorubicin—sarcoma	0.000281	0.000453	CcSEcCtD
Memantine—Flushing—Doxorubicin—sarcoma	0.000279	0.000451	CcSEcCtD
Memantine—Cardiac disorder—Doxorubicin—sarcoma	0.000279	0.000451	CcSEcCtD
Memantine—Flatulence—Epirubicin—sarcoma	0.000279	0.00045	CcSEcCtD
Memantine—GRIN1—Developmental Biology—MYOD1—sarcoma	0.000278	0.00529	CbGpPWpGaD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000278	0.00528	CbGpPWpGaD
Memantine—Tension—Epirubicin—sarcoma	0.000278	0.000448	CcSEcCtD
Memantine—Dysgeusia—Epirubicin—sarcoma	0.000277	0.000447	CcSEcCtD
Memantine—GRIN1—Axon guidance—PLCG1—sarcoma	0.000276	0.00524	CbGpPWpGaD
Memantine—Nervousness—Epirubicin—sarcoma	0.000275	0.000444	CcSEcCtD
Memantine—GRIN2B—Axon guidance—PTPRC—sarcoma	0.000275	0.00522	CbGpPWpGaD
Memantine—Back pain—Epirubicin—sarcoma	0.000274	0.000442	CcSEcCtD
Memantine—Angiopathy—Doxorubicin—sarcoma	0.000273	0.00044	CcSEcCtD
Memantine—Dizziness—Etoposide—sarcoma	0.000273	0.00044	CcSEcCtD
Memantine—Immune system disorder—Doxorubicin—sarcoma	0.000272	0.000438	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—CREB1—sarcoma	0.000272	0.00516	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MYOD1—sarcoma	0.000271	0.00515	CbGpPWpGaD
Memantine—Mediastinal disorder—Doxorubicin—sarcoma	0.000271	0.000438	CcSEcCtD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000271	0.00515	CbGpPWpGaD
Memantine—Chills—Doxorubicin—sarcoma	0.00027	0.000436	CcSEcCtD
Memantine—GRIN2B—Axon guidance—PLCG1—sarcoma	0.000269	0.00511	CbGpPWpGaD
Memantine—Arrhythmia—Doxorubicin—sarcoma	0.000269	0.000434	CcSEcCtD
Memantine—Vision blurred—Epirubicin—sarcoma	0.000267	0.00043	CcSEcCtD
Memantine—Alopecia—Doxorubicin—sarcoma	0.000266	0.000429	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—CREB1—sarcoma	0.000265	0.00503	CbGpPWpGaD
Memantine—Mental disorder—Doxorubicin—sarcoma	0.000264	0.000425	CcSEcCtD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000264	0.00501	CbGpPWpGaD
Memantine—Ill-defined disorder—Epirubicin—sarcoma	0.000263	0.000424	CcSEcCtD
Memantine—Vomiting—Etoposide—sarcoma	0.000262	0.000423	CcSEcCtD
Memantine—Malnutrition—Doxorubicin—sarcoma	0.000262	0.000423	CcSEcCtD
Memantine—Anaemia—Epirubicin—sarcoma	0.000262	0.000422	CcSEcCtD
Memantine—Agitation—Epirubicin—sarcoma	0.00026	0.00042	CcSEcCtD
Memantine—Rash—Etoposide—sarcoma	0.00026	0.000419	CcSEcCtD
Memantine—Dermatitis—Etoposide—sarcoma	0.00026	0.000419	CcSEcCtD
Memantine—Headache—Etoposide—sarcoma	0.000258	0.000417	CcSEcCtD
Memantine—Flatulence—Doxorubicin—sarcoma	0.000258	0.000416	CcSEcCtD
Memantine—Tension—Doxorubicin—sarcoma	0.000257	0.000415	CcSEcCtD
Memantine—Dysgeusia—Doxorubicin—sarcoma	0.000257	0.000414	CcSEcCtD
Memantine—Malaise—Epirubicin—sarcoma	0.000255	0.000412	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000255	0.00484	CbGpPWpGaD
Memantine—Nervousness—Doxorubicin—sarcoma	0.000255	0.00041	CcSEcCtD
Memantine—Vertigo—Epirubicin—sarcoma	0.000254	0.00041	CcSEcCtD
Memantine—Syncope—Epirubicin—sarcoma	0.000254	0.00041	CcSEcCtD
Memantine—Leukopenia—Epirubicin—sarcoma	0.000254	0.000409	CcSEcCtD
Memantine—Back pain—Doxorubicin—sarcoma	0.000253	0.000409	CcSEcCtD
Memantine—Palpitations—Epirubicin—sarcoma	0.00025	0.000404	CcSEcCtD
Memantine—Loss of consciousness—Epirubicin—sarcoma	0.000249	0.000401	CcSEcCtD
Memantine—Cough—Epirubicin—sarcoma	0.000247	0.000399	CcSEcCtD
Memantine—Vision blurred—Doxorubicin—sarcoma	0.000247	0.000398	CcSEcCtD
Memantine—GRIN1—EPH-Ephrin signaling—SRC—sarcoma	0.000247	0.00468	CbGpPWpGaD
Memantine—Convulsion—Epirubicin—sarcoma	0.000245	0.000396	CcSEcCtD
Memantine—Nausea—Etoposide—sarcoma	0.000245	0.000395	CcSEcCtD
Memantine—Hypertension—Epirubicin—sarcoma	0.000245	0.000394	CcSEcCtD
Memantine—Ill-defined disorder—Doxorubicin—sarcoma	0.000243	0.000392	CcSEcCtD
Memantine—Anaemia—Doxorubicin—sarcoma	0.000242	0.000391	CcSEcCtD
Memantine—Chest pain—Epirubicin—sarcoma	0.000241	0.000389	CcSEcCtD
Memantine—Arthralgia—Epirubicin—sarcoma	0.000241	0.000389	CcSEcCtD
Memantine—Myalgia—Epirubicin—sarcoma	0.000241	0.000389	CcSEcCtD
Memantine—Agitation—Doxorubicin—sarcoma	0.000241	0.000388	CcSEcCtD
Memantine—GRIN2B—EPH-Ephrin signaling—SRC—sarcoma	0.00024	0.00456	CbGpPWpGaD
Memantine—Anxiety—Epirubicin—sarcoma	0.00024	0.000388	CcSEcCtD
Memantine—GRIN1—EPH-Ephrin signaling—VEGFA—sarcoma	0.00024	0.00456	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—CREB1—sarcoma	0.00024	0.00455	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TP53—sarcoma	0.000239	0.00454	CbGpPWpGaD
Memantine—Discomfort—Epirubicin—sarcoma	0.000238	0.000384	CcSEcCtD
Memantine—Malaise—Doxorubicin—sarcoma	0.000236	0.000381	CcSEcCtD
Memantine—Dry mouth—Epirubicin—sarcoma	0.000236	0.00038	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—IL2—sarcoma	0.000236	0.00447	CbGpPWpGaD
Memantine—Vertigo—Doxorubicin—sarcoma	0.000235	0.00038	CcSEcCtD
Memantine—Syncope—Doxorubicin—sarcoma	0.000235	0.000379	CcSEcCtD
Memantine—Leukopenia—Doxorubicin—sarcoma	0.000235	0.000378	CcSEcCtD
Memantine—GRIN2B—EPH-Ephrin signaling—VEGFA—sarcoma	0.000234	0.00445	CbGpPWpGaD
Memantine—Confusional state—Epirubicin—sarcoma	0.000233	0.000376	CcSEcCtD
Memantine—Palpitations—Doxorubicin—sarcoma	0.000232	0.000373	CcSEcCtD
Memantine—Oedema—Epirubicin—sarcoma	0.000231	0.000373	CcSEcCtD
Memantine—Loss of consciousness—Doxorubicin—sarcoma	0.00023	0.000371	CcSEcCtD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.00023	0.00437	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—CCND1—sarcoma	0.00023	0.00436	CbGpPWpGaD
Memantine—Infection—Epirubicin—sarcoma	0.00023	0.00037	CcSEcCtD
Memantine—Cough—Doxorubicin—sarcoma	0.000229	0.000369	CcSEcCtD
Memantine—Shock—Epirubicin—sarcoma	0.000227	0.000367	CcSEcCtD
Memantine—Convulsion—Doxorubicin—sarcoma	0.000227	0.000366	CcSEcCtD
Memantine—Nervous system disorder—Epirubicin—sarcoma	0.000227	0.000366	CcSEcCtD
Memantine—Thrombocytopenia—Epirubicin—sarcoma	0.000226	0.000365	CcSEcCtD
Memantine—Hypertension—Doxorubicin—sarcoma	0.000226	0.000365	CcSEcCtD
Memantine—Tachycardia—Epirubicin—sarcoma	0.000226	0.000364	CcSEcCtD
Memantine—Skin disorder—Epirubicin—sarcoma	0.000225	0.000362	CcSEcCtD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000224	0.00426	CbGpPWpGaD
Memantine—Hyperhidrosis—Epirubicin—sarcoma	0.000223	0.00036	CcSEcCtD
Memantine—Myalgia—Doxorubicin—sarcoma	0.000223	0.00036	CcSEcCtD
Memantine—Chest pain—Doxorubicin—sarcoma	0.000223	0.00036	CcSEcCtD
Memantine—Arthralgia—Doxorubicin—sarcoma	0.000223	0.00036	CcSEcCtD
Memantine—Anxiety—Doxorubicin—sarcoma	0.000222	0.000359	CcSEcCtD
Memantine—Discomfort—Doxorubicin—sarcoma	0.00022	0.000355	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—JUN—sarcoma	0.00022	0.00418	CbGpPWpGaD
Memantine—Anorexia—Epirubicin—sarcoma	0.00022	0.000355	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000219	0.00415	CbGpPWpGaD
Memantine—Dry mouth—Doxorubicin—sarcoma	0.000218	0.000352	CcSEcCtD
Memantine—Hypotension—Epirubicin—sarcoma	0.000216	0.000348	CcSEcCtD
Memantine—Confusional state—Doxorubicin—sarcoma	0.000216	0.000348	CcSEcCtD
Memantine—Oedema—Doxorubicin—sarcoma	0.000214	0.000345	CcSEcCtD
Memantine—Infection—Doxorubicin—sarcoma	0.000212	0.000343	CcSEcCtD
Memantine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000211	0.00034	CcSEcCtD
Memantine—Shock—Doxorubicin—sarcoma	0.00021	0.000339	CcSEcCtD
Memantine—Nervous system disorder—Doxorubicin—sarcoma	0.00021	0.000338	CcSEcCtD
Memantine—Thrombocytopenia—Doxorubicin—sarcoma	0.000209	0.000338	CcSEcCtD
Memantine—Insomnia—Epirubicin—sarcoma	0.000209	0.000337	CcSEcCtD
Memantine—GRIN1—Transmission across Chemical Synapses—CREB1—sarcoma	0.000209	0.00397	CbGpPWpGaD
Memantine—Tachycardia—Doxorubicin—sarcoma	0.000209	0.000337	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—TP53—sarcoma	0.000209	0.00396	CbGpPWpGaD
Memantine—Skin disorder—Doxorubicin—sarcoma	0.000208	0.000335	CcSEcCtD
Memantine—Paraesthesia—Epirubicin—sarcoma	0.000208	0.000335	CcSEcCtD
Memantine—Hyperhidrosis—Doxorubicin—sarcoma	0.000207	0.000333	CcSEcCtD
Memantine—Dyspnoea—Epirubicin—sarcoma	0.000206	0.000332	CcSEcCtD
Memantine—Somnolence—Epirubicin—sarcoma	0.000205	0.000331	CcSEcCtD
Memantine—Anorexia—Doxorubicin—sarcoma	0.000204	0.000329	CcSEcCtD
Memantine—GRIN2B—Transmission across Chemical Synapses—CREB1—sarcoma	0.000204	0.00387	CbGpPWpGaD
Memantine—Dyspepsia—Epirubicin—sarcoma	0.000203	0.000328	CcSEcCtD
Memantine—GRIN2B—Alzheimers Disease—TP53—sarcoma	0.000203	0.00386	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—PTPRC—sarcoma	0.000201	0.00382	CbGpPWpGaD
Memantine—Decreased appetite—Epirubicin—sarcoma	0.000201	0.000324	CcSEcCtD
Memantine—CYP2A6—Fluoropyrimidine Activity—TP53—sarcoma	0.0002	0.0038	CbGpPWpGaD
Memantine—Hypotension—Doxorubicin—sarcoma	0.0002	0.000322	CcSEcCtD
Memantine—Gastrointestinal disorder—Epirubicin—sarcoma	0.0002	0.000322	CcSEcCtD
Memantine—Fatigue—Epirubicin—sarcoma	0.000199	0.000321	CcSEcCtD
Memantine—GRIN2A—Transmission across Chemical Synapses—MDM2—sarcoma	0.000198	0.00376	CbGpPWpGaD
Memantine—Constipation—Epirubicin—sarcoma	0.000198	0.000319	CcSEcCtD
Memantine—Pain—Epirubicin—sarcoma	0.000198	0.000319	CcSEcCtD
Memantine—GRIN1—Developmental Biology—PLCG1—sarcoma	0.000197	0.00374	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—PTPRC—sarcoma	0.000196	0.00373	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—JUN—sarcoma	0.000195	0.00371	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000195	0.000314	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—CTNNB1—sarcoma	0.000194	0.00368	CbGpPWpGaD
Memantine—Insomnia—Doxorubicin—sarcoma	0.000193	0.000312	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000193	0.00365	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—PLCG1—sarcoma	0.000192	0.00365	CbGpPWpGaD
Memantine—Paraesthesia—Doxorubicin—sarcoma	0.000192	0.00031	CcSEcCtD
Memantine—Dyspnoea—Doxorubicin—sarcoma	0.000191	0.000307	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—JUN—sarcoma	0.000191	0.00362	CbGpPWpGaD
Memantine—Feeling abnormal—Epirubicin—sarcoma	0.00019	0.000307	CcSEcCtD
Memantine—Somnolence—Doxorubicin—sarcoma	0.00019	0.000307	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—CTNNB1—sarcoma	0.000189	0.00359	CbGpPWpGaD
Memantine—Gastrointestinal pain—Epirubicin—sarcoma	0.000189	0.000305	CcSEcCtD
Memantine—Dyspepsia—Doxorubicin—sarcoma	0.000188	0.000304	CcSEcCtD
Memantine—Decreased appetite—Doxorubicin—sarcoma	0.000186	0.0003	CcSEcCtD
Memantine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000185	0.000298	CcSEcCtD
Memantine—Fatigue—Doxorubicin—sarcoma	0.000184	0.000297	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—MYC—sarcoma	0.000184	0.0035	CbGpPWpGaD
Memantine—Urticaria—Epirubicin—sarcoma	0.000184	0.000296	CcSEcCtD
Memantine—GRIN2A—Neuronal System—CREB1—sarcoma	0.000184	0.00349	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—JUN—sarcoma	0.000183	0.00348	CbGpPWpGaD
Memantine—Constipation—Doxorubicin—sarcoma	0.000183	0.000295	CcSEcCtD
Memantine—Pain—Doxorubicin—sarcoma	0.000183	0.000295	CcSEcCtD
Memantine—Body temperature increased—Epirubicin—sarcoma	0.000183	0.000295	CcSEcCtD
Memantine—Abdominal pain—Epirubicin—sarcoma	0.000183	0.000295	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000182	0.00345	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—EGFR—sarcoma	0.00018	0.00342	CbGpPWpGaD
Memantine—Feeling abnormal—Doxorubicin—sarcoma	0.000176	0.000284	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—SRC—sarcoma	0.000175	0.00333	CbGpPWpGaD
Memantine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000175	0.000282	CcSEcCtD
Memantine—GRIN1—EPH-Ephrin signaling—HRAS—sarcoma	0.000174	0.0033	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—MDM2—sarcoma	0.000173	0.00328	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—SRC—sarcoma	0.000171	0.00325	CbGpPWpGaD
Memantine—Hypersensitivity—Epirubicin—sarcoma	0.00017	0.000275	CcSEcCtD
Memantine—Urticaria—Doxorubicin—sarcoma	0.00017	0.000274	CcSEcCtD
Memantine—GRIN2B—EPH-Ephrin signaling—HRAS—sarcoma	0.000169	0.00321	CbGpPWpGaD
Memantine—Body temperature increased—Doxorubicin—sarcoma	0.000169	0.000273	CcSEcCtD
Memantine—Abdominal pain—Doxorubicin—sarcoma	0.000169	0.000273	CcSEcCtD
Memantine—GRIN2B—Transmission across Chemical Synapses—MDM2—sarcoma	0.000169	0.0032	CbGpPWpGaD
Memantine—Asthenia—Epirubicin—sarcoma	0.000166	0.000267	CcSEcCtD
Memantine—Pruritus—Epirubicin—sarcoma	0.000164	0.000264	CcSEcCtD
Memantine—GRIN1—Axon guidance—KDR—sarcoma	0.000162	0.00308	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.00016	0.00304	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—CREB1—sarcoma	0.00016	0.00304	CbGpPWpGaD
Memantine—Diarrhoea—Epirubicin—sarcoma	0.000158	0.000255	CcSEcCtD
Memantine—GRIN2B—Axon guidance—KDR—sarcoma	0.000158	0.003	CbGpPWpGaD
Memantine—Hypersensitivity—Doxorubicin—sarcoma	0.000158	0.000254	CcSEcCtD
Memantine—DRD2—G alpha (i) signalling events—CXCR4—sarcoma	0.000157	0.00299	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—CREB1—sarcoma	0.000156	0.00296	CbGpPWpGaD
Memantine—Asthenia—Doxorubicin—sarcoma	0.000153	0.000247	CcSEcCtD
Memantine—Dizziness—Epirubicin—sarcoma	0.000153	0.000246	CcSEcCtD
Memantine—GRIN2A—Neuronal System—MDM2—sarcoma	0.000152	0.00288	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TP53—sarcoma	0.000151	0.00287	CbGpPWpGaD
Memantine—Pruritus—Doxorubicin—sarcoma	0.000151	0.000244	CcSEcCtD
Memantine—Vomiting—Epirubicin—sarcoma	0.000147	0.000237	CcSEcCtD
Memantine—Diarrhoea—Doxorubicin—sarcoma	0.000146	0.000236	CcSEcCtD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.000146	0.00277	CbGpPWpGaD
Memantine—Rash—Epirubicin—sarcoma	0.000146	0.000235	CcSEcCtD
Memantine—Dermatitis—Epirubicin—sarcoma	0.000146	0.000235	CcSEcCtD
Memantine—Headache—Epirubicin—sarcoma	0.000145	0.000234	CcSEcCtD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000145	0.00275	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—CREB1—sarcoma	0.000142	0.0027	CbGpPWpGaD
Memantine—Dizziness—Doxorubicin—sarcoma	0.000141	0.000228	CcSEcCtD
Memantine—GRIN1—Developmental Biology—FOXO1—sarcoma	0.00014	0.00265	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—CREB1—sarcoma	0.000138	0.00263	CbGpPWpGaD
Memantine—Nausea—Epirubicin—sarcoma	0.000137	0.000221	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—FOXO1—sarcoma	0.000136	0.00259	CbGpPWpGaD
Memantine—Vomiting—Doxorubicin—sarcoma	0.000136	0.000219	CcSEcCtD
Memantine—Rash—Doxorubicin—sarcoma	0.000135	0.000217	CcSEcCtD
Memantine—Dermatitis—Doxorubicin—sarcoma	0.000135	0.000217	CcSEcCtD
Memantine—Headache—Doxorubicin—sarcoma	0.000134	0.000216	CcSEcCtD
Memantine—GRIN1—Neuronal System—MDM2—sarcoma	0.000132	0.00252	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—MMP2—sarcoma	0.000132	0.00251	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—MDM2—sarcoma	0.000129	0.00245	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MMP2—sarcoma	0.000129	0.00245	CbGpPWpGaD
Memantine—Nausea—Doxorubicin—sarcoma	0.000127	0.000205	CcSEcCtD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000126	0.0024	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000125	0.00238	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—HRAS—sarcoma	0.000123	0.00234	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000123	0.00234	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—HRAS—sarcoma	0.00012	0.00228	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—KDR—sarcoma	0.000116	0.0022	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—KDR—sarcoma	0.000113	0.00214	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—HRAS—sarcoma	0.000109	0.00207	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—CREB1—sarcoma	0.000109	0.00206	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CREB1—sarcoma	0.000101	0.00192	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CREB1—sarcoma	9.88e-05	0.00188	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—CREB1—sarcoma	9.55e-05	0.00181	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCR4—sarcoma	9.53e-05	0.00181	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—HRAS—sarcoma	9.49e-05	0.0018	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MMP2—sarcoma	9.44e-05	0.00179	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—HRAS—sarcoma	9.25e-05	0.00176	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP2—sarcoma	9.2e-05	0.00175	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—SRC—sarcoma	9.16e-05	0.00174	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—MDM2—sarcoma	8.99e-05	0.00171	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—SRC—sarcoma	8.93e-05	0.0017	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—VEGFA—sarcoma	8.93e-05	0.00169	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—NRAS—sarcoma	8.82e-05	0.00167	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—VEGFA—sarcoma	8.7e-05	0.00165	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—NRAS—sarcoma	8.6e-05	0.00163	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—HRAS—sarcoma	8.33e-05	0.00158	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—CREB1—sarcoma	8.32e-05	0.00158	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—EGFR—sarcoma	8.03e-05	0.00153	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—EGFR—sarcoma	7.83e-05	0.00149	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—KRAS—sarcoma	7.59e-05	0.00144	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—KRAS—sarcoma	7.4e-05	0.0014	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—HRAS—sarcoma	7.27e-05	0.00138	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CTNNB1—sarcoma	7.24e-05	0.00137	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—HRAS—sarcoma	7.09e-05	0.00135	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CTNNB1—sarcoma	7.05e-05	0.00134	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—MDM2—sarcoma	6.89e-05	0.00131	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—JUN—sarcoma	6.87e-05	0.0013	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—SRC—sarcoma	6.54e-05	0.00124	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—HRAS—sarcoma	6.45e-05	0.00122	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—SRC—sarcoma	6.38e-05	0.00121	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—sarcoma	6.37e-05	0.00121	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—NRAS—sarcoma	6.29e-05	0.00119	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—HRAS—sarcoma	6.29e-05	0.00119	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—sarcoma	6.21e-05	0.00118	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—NRAS—sarcoma	6.13e-05	0.00116	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EGFR—sarcoma	5.73e-05	0.00109	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EGFR—sarcoma	5.59e-05	0.00106	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—KRAS—sarcoma	5.42e-05	0.00103	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCR4—sarcoma	5.38e-05	0.00102	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—KRAS—sarcoma	5.28e-05	0.001	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—HRAS—sarcoma	4.93e-05	0.000937	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCR4—sarcoma	4.89e-05	0.000928	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ENO2—sarcoma	4.8e-05	0.000911	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—HBA1—sarcoma	4.77e-05	0.000906	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—HRAS—sarcoma	4.6e-05	0.000874	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TLE1—sarcoma	4.53e-05	0.000861	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—sarcoma	4.53e-05	0.000861	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HRAS—sarcoma	4.49e-05	0.000852	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ENO2—sarcoma	4.41e-05	0.000837	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HBA1—sarcoma	4.38e-05	0.000831	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PLCG1—sarcoma	4.07e-05	0.000773	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFC—sarcoma	3.83e-05	0.000726	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—HRAS—sarcoma	3.78e-05	0.000718	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PLCG1—sarcoma	3.74e-05	0.00071	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ENO2—sarcoma	3.56e-05	0.000675	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HBA1—sarcoma	3.53e-05	0.000671	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FLT1—sarcoma	3.06e-05	0.000581	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PLCG1—sarcoma	3.02e-05	0.000573	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PLCG1—sarcoma	3.01e-05	0.000571	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCR4—sarcoma	2.89e-05	0.000548	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ATF1—sarcoma	2.86e-05	0.000542	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ENO2—sarcoma	2.69e-05	0.00051	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HBA1—sarcoma	2.67e-05	0.000507	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CREB1—sarcoma	2.62e-05	0.000497	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PLCG1—sarcoma	2.28e-05	0.000433	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1R—sarcoma	2.24e-05	0.000425	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FOXO1—sarcoma	2.13e-05	0.000405	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL2—sarcoma	2.13e-05	0.000405	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PDGFRB—sarcoma	2.13e-05	0.000404	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PDGFRA—sarcoma	2.1e-05	0.000398	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL2—sarcoma	1.94e-05	0.000368	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KDR—sarcoma	1.76e-05	0.000335	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KIT—sarcoma	1.63e-05	0.000309	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—NRAS—sarcoma	1.63e-05	0.000309	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CREB1—sarcoma	1.55e-05	0.000294	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—sarcoma	1.48e-05	0.000281	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KRAS—sarcoma	1.4e-05	0.000266	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MDM2—sarcoma	1.28e-05	0.000243	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HRAS—sarcoma	1.19e-05	0.000226	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL2—sarcoma	1.14e-05	0.000217	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCND1—sarcoma	1.11e-05	0.000212	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JUN—sarcoma	1.11e-05	0.000211	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CTNNB1—sarcoma	1.1e-05	0.00021	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SRC—sarcoma	9.98e-06	0.000189	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—sarcoma	9.72e-06	0.000185	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NRAS—sarcoma	9.6e-06	0.000182	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—sarcoma	8.94e-06	0.00017	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—sarcoma	8.75e-06	0.000166	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KRAS—sarcoma	8.26e-06	0.000157	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—sarcoma	7.34e-06	0.000139	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HRAS—sarcoma	7.02e-06	0.000133	CbGpPWpGaD
